1. Karger S. An International System for Human Cytogenetic Nomenclature. In: Shaffer LG, Tommerup N, eds. Basel in Collaboration with Cytogenetics and Genome Research 2005.
2. Ayton PM, Cleary ML. MLL in normal and malignant hematopoiesis. In: Ravid K, Licht JD. Transcription Factors Willey-Liss, Inc 2001;25:447–463.
3. Boveri T. Uber mehrpolige mitozen als mittel zur analyse dez zellkerus. Verhand Physik-Med Ges Wurzurg. 1902;35:67–90.
4. Carlson RW, Moench NJ, Hammond ME et al. HER2 testing in breast cancer: NCCN Task Force report and recommendations. J Nat Compr Cancer Netw. 2006;Suppl 3:S1–22; quiz S23–24.
5. Cauwelier B, Dastieve N, Cools J, et al. Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRB rearrangements and putative new T cell oncogenes. Leukemia 2006;20:1238–1244.